Predictive Toxicity and Response to Immunotherapy in Patients with Metastatic Non Small Cell Lung Cancer (IMMUNOPREDICT)

被引：0
|
作者：
Nguyen, J. [1 ]
Quere, G. [1 ]
Descourt, R. [1 ]
Geier, M. [1 ]
Babey, H. [1 ]
Saliou, P. [1 ]
Picard, J. [1 ]
Dhamelincourt, E. [1 ]
Fave, T. [1 ]
Laune, Q. [1 ]
Simaki, A. [1 ]
Renaud, E. [1 ]
Cornec, D. [1 ]
机构：
[1] CHRU Brest, Brest, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
immunotherapy; prediction; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.02-08
引用
收藏
页码：S618 / S618
页数：1
相关论文
共 50 条
  • [1] Pretreatment predictive score for metastatic non-small cell lung cancer patients treated with immunotherapy
    Musaelyan, A.
    Moiseyenko, F.
    Emileva, T.
    Oganesyan, A. P.
    Urtenova, M.
    Odintsova, S.
    Chistyakov, I.
    Akopov, A.
    Orlov, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S77 - S77
  • [2] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [3] A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non-small-cell lung cancer and melanoma
    Shaked, Yuval
    Benguigui, Madeleine
    Halaban, Ruth
    Bacchiocchi, Antonella
    Kamer, Iris
    Bar, Jair
    Lotem, Michal
    Shen-Orr, Shai
    Sznol, Mario
    Cooper, Tim J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Long-term Outcomes and Toxicity in Patients with Metastatic Non Small Cell Lung Cancer Treated with Immunotherapy Containing Regimens
    Maddula, M.
    Brown, L. J.
    Gao, B.
    da Silva, I. Pires
    Nagrial, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S622 - S622
  • [5] Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancer
    Prasanna, Thiru
    Arasaratnam, Mal
    Boyer, Michael
    McNeil, Catriona
    Barnet, Megan B.
    Asher, Rebecca
    Hui, Rina
    Nagrial, Adnan
    Kao, Steven
    IMMUNOTHERAPY, 2019, 11 (08) : 657 - 665
  • [6] Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy
    Stenehjem, David
    Lubinga, Solomon
    Betts, Keith A.
    Tang, Wenxi
    Jenkins, Mads
    Yuan, Yong
    Hartman, John
    Rao, Sumati
    Lam, Jenny
    Waterhouse, David
    FUTURE ONCOLOGY, 2021, 17 (22) : 2940 - 2949
  • [7] Improving survival for patients with metastatic non-small cell lung cancer in the immunotherapy era
    Zhang, David
    Rohatgi, Anjali
    CANCER, 2025, 131 (01)
  • [8] Impact of Antibiotics on Outcome of Metastatic Non Small Cell Lung Cancer Patients Treated with Immunotherapy
    Galli, G.
    Poggi, M.
    Fuca, G.
    Imbimbo, M.
    Proto, C.
    Signorelli, D.
    Vitali, M.
    Zilembo, N.
    Ganzinelli, M.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S389 - S389
  • [9] Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
    H. Adderley
    F. H. Blackhall
    C. R. Lindsay
    Cancer Immunology, Immunotherapy, 2021, 70 : 589 - 595
  • [10] Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
    Adderley, H.
    Blackhall, F. H.
    Lindsay, C. R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 589 - 595
12345